Skip to content
  • Home
  • Journalists
    • Headlines
  • Community
    • Businesses
    • Jobs
    • Learning
    • Marketplace
  • Store
(@)

California Sues Companies Over Insulin Prices, Joining Other States

The New York Times – Business:

The state is taking action against three major drug companies and the big pharmacy benefit managers in an effort to temper costs for people with diabetes.

Benjamin Ryan
Author: Benjamin Ryan

This post first appeared in The New York Times – Business. Read the original article.

Written by

Benjamin Ryan

in

Diabetes, Drugs (Pharmaceuticals), Health Insurance and Managed Care, Inflation Reduction Act of 2022, Insulin, Law and Legislation, Medicare, Prices (Fares, Fees and Rates), Research, Suits and Litigation (Civil)
←Sade, Snoop Dogg, Teddy Riley Among List Of Inductees For 2023 Songwriters Hall Of Fame
Read Your Way Through Boston→

More posts

  • Brie and Nikki Bella Hot Shots To Celebrate Their 43rd Birthday!

  • Trump’s grip on GOP tested as MAGA allies head for exit

  • At least 24 dead in Nigeria when boat going to funeral capsizes

  • Kaitlan Collins Notes ‘Real Time’ Absence Was Due To White House Press Conference

About Us


Support Us

Trademark & Copyright 1998 – 2025 · MOSAEC

  • Facebook
  • Instagram
  • LinkedIn
  • YouTube